Submission of Confirmation Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31 March 2026

SHILPAMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+3.6%1-day move

₹392.00

prior close

₹392.90

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.9+0.4+0.5-1.7+3.6+6.8+7.7+6.1+5.4+4.9+2.7+12.9+35.4+52.3

Up moveDown movePending

AI summary

Shilpa Medicare Limited has submitted a routine regulatory compliance certificate for Q4 FY2026 (ending March 31, 2026). The certificate from Registrar and Share Transfer Agent KFin Technologies Limited confirms that details of securities dematerialized/rematerialized during the quarter have been properly furnished to both NSE and BSE as required under SEBI regulations. This filing ensures the company maintains its regulatory obligations regarding share dematerialization records. The certificate was issued on April 2, 2026, and submitted to exchanges on April 6, 2026, by Company Secretary Ritu Tiwary.

Likely market impact

This is a standard regulatory compliance filing with no material impact on the stock or shareholder value. It simply confirms proper reporting of share dematerialization/rematerialization activities to exchanges.